Abstract:Abstract:ObjectiveTo investigate the role of Pglycoprotein (Pgp) in EphA2mediated paclitaxel resistance in nasopharyngeal carcinoma (NPC) in vitro.MethodsEphA2 expression in NPC cell lines was modulated by lentiviral vector, Pgp expression was detected by western blotting accordingly. Pgp was downregulated in normal or EphA2 overexpressed NPC cell lines and its survival rate after paclitaxel treatment was determined by CCK8. PI3K/Akt specific inhibitor LY294002 was added to EphA2 upregulated NPC cells, the expressions of Akt, pAkt and Pgp were determined by western blotting after 48h paclitaxel treatment.ResultsThe expression of Pgp was downregulated in the normal EphA2 group and upregulated in the overexpressed EphA2 group. After paclitaxel treatment, the survival rate of NPC cells in Pgp knock down group (52.1±3.7%) was significantly lower than those of the negative control group (72.4±6.2%) and blank control group (68.9±4.0%) (both P<0.05).Similar results were also observed in overexpressed EphA2 group [(36.1±5.1%) vs (58.2±5.8%);(36.1±5.1%)vs(57.9±6.2%) (both P<0.05)]. In paclitaxel treated EphA2 overexpressed NPC cell line, LY294002 inhibited the expressions of pAkt and Pgp but not that of total Akt.ConclusionEphA2 modulates paclitaxel resistance in NPC cells via regulation of Pgp, and PI3K/Akt path way may be involved in this process.